Macular degeneration: the latest in current medical management.
Lim
Jennifer I
JI
Keck School of Medicine, Department of Ophthalmology, Doheny Eye Institute, University of Southern California, Los Angeles 90033, USA. jennifil@usc.edu
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007432:Intraoperative Period; D008268:Macular Degeneration / Q000188:drug therapy*; D013267:Stilbenes / Q000627:therapeutic use*; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D005938:Glucocorticoids; D013267:Stilbenes; D014222:Triamcinolone Acetonide; C058728:fosbretabulin